Pharmacovigilance services for the Pharmaceutical Industry.

PVpharm contributes to a recent article about the Covid vaccine

  • September 23, 2021

"Pharmacovigilance in times of COVID-19 vaccines", is an article published in the Spanish journal Pharmatech and in which José Alberto Ayala Ortiz has been co-author. The world is facing the unprecedented challenge of the SARS-CoV-2 pandemic. The hope for a normal life relied on vaccines is compromised by messages that question them. For this reason, pharmacovigilance activities carried out by authorities, pharmaceutical laboratories, health professionals and patients are essential to assess information and not to rely on "fake news". In this regard, the article aims to highlight the role of pharmacovigilance. It is important that society, in addition to being…

Continue Reading

PVpharm opens an office in Prague

  • March 11, 2021

We are happy to announce that PVpharm is opening an office in Prague (Czech Republic). For all our partners and collaborators we are welcoming you at our new location! PVpharm S.L. - Prague, Smichoff, Plzeňská 3350/18, 150 00 Praha 5-Smíchov, Chequia

Continue Reading

PVpharm provides Local Contact Persons for Pharmacovigilance (LCPPVs) in the EU and the UK

  • January 22, 2021

PVpharm provides the Local Contact Person for Pharmacovigilance (LCPPV) in all EU countries and UK, besides we can also provide the EU Qualified Person for Pharmacovigilance (EU QPPV), UK QPPV and and Deputy persons with large knowledge and experience of the industry. Any medicinal product cannot be authorized in the EU without a Qualified Person for Pharmacovigilance (EU QPPV). The EU QPPV is responsible for the establishment and maintenance of the MAH's PV system, therefore must have adequate oversight and authority to affect the performance of the quality system and the PV activities, and to maintain and improve compliance with…

Continue Reading